Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $18.1B |
| FY2017, ended Dec 31, 2017 | $20.0B |
| FY2018, ended Dec 31, 2018 | $18.5B |
| FY2019, ended Dec 31, 2019 | $35.1B |
| FY2020, ended Dec 31, 2020 | $47.9B |
| FY2021, ended Dec 31, 2021 | $49.2B |
| FY2022, ended Dec 31, 2022 | $37.5B |
| FY2023, ended Dec 31, 2023 | $47.7B |
| FY2024, ended Dec 31, 2024 | $41.9B |
| FY2025, ended Dec 31, 2025 | $109B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $120B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.71B |
| FY2017, ended Dec 31, 2017 | $7.38B |
| FY2018, ended Dec 31, 2018 | $7.25B |
| FY2019, ended Dec 31, 2019 | $9.74B |
| FY2020, ended Dec 31, 2020 | $11.5B |
| FY2021, ended Dec 31, 2021 | $12.2B |
| FY2022, ended Dec 31, 2022 | $11.9B |
| FY2023, ended Dec 31, 2023 | $11.8B |
| FY2024, ended Dec 31, 2024 | $18.7B |
| FY2025, ended Dec 31, 2025 | $22.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $26.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$629M | $1.65B |
| FY2017, ended Dec 31, 2017 | −$114M | $1.26B |
| FY2018, ended Dec 31, 2018 | $341M | $795M |
| FY2019, ended Dec 31, 2019 | $2.81B | $1.40B |
| FY2020, ended Dec 31, 2020 | $2.83B | $3.58B |
| FY2021, ended Dec 31, 2021 | $1.17B | $2.63B |
| FY2022, ended Dec 31, 2022 | −$429M | $1.09B |
| FY2023, ended Dec 31, 2023 | −$2.49B | $97.0M |
| FY2024, ended Dec 31, 2024 | $3.35B | $2.96B |
| FY2025, ended Dec 31, 2025 | $7.08B | $7.30B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $9.24B | $10.1B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.76B |
| FY2017, ended Dec 31, 2017 | $3.26B |
| FY2018, ended Dec 31, 2018 | $3.40B |
| FY2019, ended Dec 31, 2019 | $2.24B |
| FY2020, ended Dec 31, 2020 | $5.54B |
| FY2021, ended Dec 31, 2021 | $4.99B |
| FY2022, ended Dec 31, 2022 | $2.88B |
| FY2023, ended Dec 31, 2023 | $3.00B |
| FY2024, ended Dec 31, 2024 | $3.62B |
| FY2025, ended Dec 31, 2025 | $7.65B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $8.83B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.62B |
| FY2017, ended Dec 31, 2017 | $4.04B |
| FY2018, ended Dec 31, 2018 | $4.04B |
| FY2019, ended Dec 31, 2019 | $6.17B |
| FY2020, ended Dec 31, 2020 | $6.08B |
| FY2021, ended Dec 31, 2021 | $5.71B |
| FY2022, ended Dec 31, 2022 | $5.57B |
| FY2023, ended Dec 31, 2023 | $8.87B |
| FY2024, ended Dec 31, 2024 | $8.48B |
| FY2025, ended Dec 31, 2025 | $5.12B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $5.09B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 95.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 531M |
| FY2017, ended Dec 31, 2017 | 533M |
| FY2018, ended Dec 31, 2018 | 533M |
| FY2019, ended Dec 31, 2019 | 808M |
| FY2020, ended Dec 31, 2020 | 800M |
| FY2021, ended Dec 31, 2021 | 793M |
| FY2022, ended Dec 31, 2022 | 794M |
| FY2023, ended Dec 31, 2023 | 1.15B |
| FY2024, ended Dec 31, 2024 | 1.13B |
| FY2025, ended Dec 31, 2025 | 1.09B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 1.04B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $70.0M | — |
| FY2017, ended Dec 31, 2017 | — | $70.0M | — |
| FY2018, ended Dec 31, 2018 | $98.0M | $76.0M | — |
| FY2019, ended Dec 31, 2019 | $479M | $121M | — |
| FY2020, ended Dec 31, 2020 | $521M | $84.0M | — |
| FY2021, ended Dec 31, 2021 | $525M | $72.0M | — |
| FY2022, ended Dec 31, 2022 | $0 | $76.0M | — |
| FY2023, ended Dec 31, 2023 | $0 | $80.0M | $13.5B |
| FY2024, ended Dec 31, 2024 | $1.25B | $89.0M | — |
| FY2025, ended Dec 31, 2025 | $2.30B | $99.0M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $5.67B | — | — |
Valuation
At current price- Market Cap
- $117B
- P/E
- 12.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.4×
- Price / Book
- 3.3×
- EV / EBITDA
- 6.9×
Growth
Trailing 12 months- Revenue (TTM)
- $26.6B
- Revenue Growth YoY
- 23.7%
- Revenue CAGR 3Y
- 23.9%
- Revenue CAGR 5Y
- 14.5%
- EPS Growth YoY
- 34.1%
- Net Income Growth YoY
- 28.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 51.8%
- Net Margin
- 34.7%
- FCF Margin
- 37.9%
- Return on Equity
- 26.8%
Earnings
Trailing 12 months- Net Income
- $9.24B
- EPS (diluted)
- $8.62
- EBITDA
- $16.3B
- Operating Income
- $13.8B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $8.83B
- Total Debt
- $5.09B
- Net Cash
- $3.74B
- Total Assets
- $58.2B
- Total Liabilities
- $22.3B
- Shareholders' Equity
- $35.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $13.1B
- Capital Expenditure
- $3.02B
- Free Cash Flow
- $10.1B
Dividends and risk
Last 12 months- Dividend Yield
- 0.9%
- Dividend / Share
- $1.03
- Beta (5Y)
- 0.52
Every ratio is calculated from the company’s reported figures.